Accumulating evidence indicates that tumor‐derived factors downregulate NKp30, NKp46, and NKG2D expression, resulting in diminished cytotoxic activity of NK cells against tumors and contributing to NK cell senescence. Here, KLRK1 is linked to neoplasm.